Health ❯Pharmaceuticals
Contaminated Drugs Adverse Effects Mifepristone FDA Regulations Counterfeit Drugs Regulatory Actions Cancer Risks FDA Approval Cancer Risk Health Risks
Findings from two JAMA Network Open studies have prompted calls for routine ophthalmic screening to weigh rare ocular events against the drugs’ cardiometabolic gains.
